Wyeth appoints Road

Drug company Wyeth Pharmaceuticals has appointed specialist healthcare agency Road to support its haemophilia division.

Jane Boston: heads up haemophilia brief
Jane Boston: heads up haemophilia brief

Road will be working on a series of medical education and web-based communication tools for ReFacto, Wyeth's recombinant Factor VIII clotting agent.

Road senior consultant Jane Boston will head up the account.

Haemophilia is a rare blood condition caused by a deficiency in an essential clotting factor. It is a life-long genetic condition that affects approximately 6,000 people in the UK.

‘While the numbers of patients with haemophilia is fairly small, the impact of the condition spreads much further,' said Boston. ‘There are numerous health professionals and patient stakeholders, all crucially important in managing the condition. We aim to touch them all with information to increase awareness and improve understanding.'

 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.